Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 11;9(3):467-485.
doi: 10.3934/microbiol.2023025. eCollection 2023.

Biofilm: The invisible culprit in catheter-induced candidemia

Affiliations
Review

Biofilm: The invisible culprit in catheter-induced candidemia

Meiliyana Wijaya et al. AIMS Microbiol. .

Abstract

Candidemia is the most common form of invasive fungal infection associated with several risk factors, and one of them is the use of medical devices, to which microbial biofilms can attach. Candidemia related to the use of peripheral intravascular and central venous catheters (CVC) is referred to as Candida catheter-related bloodstream infection, with more than 90% being related to CVC usage. The infection is associated with a higher morbidity and mortality rate than nosocomial bacterial infections. Candida spp. can protect themselves from the host immune system and antifungal drugs because of the biofilm structure, which is potentiated by the extracellular matrix (ECM). Candida albicans and Candida parapsilosis are the most pathogenic species often found to form biofilms associated with catheter usage. Biofilm formation of C. albicans includes four mechanisms: attachment, morphogenesis, maturation and dispersion. The biofilms formed between C. albicans and non-albicans spp. differ in ECM structure and composition and are associated with the persistence of colonization to infection for various catheter materials and antifungal resistance. Efforts to combat Candida spp. biofilm formation on catheters are still challenging because not all patients, especially those who are critically ill, can be recommended for catheter removal; also to be considered are the characteristics of the biofilm itself, which readily colonizes the permanent medical devices used. The limited choice and increasing systemic antifungal resistance also make treating it more difficult. Hence, alternative strategies have been developed to manage Candida biofilm. Current options for prevention or therapy in combination with systemic antifungal medications include lock therapy, catheter coating, natural peptide products and photodynamic inactivation.

Keywords: biofilm; candidemia; catheter; extracellular matrix; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest that could affect the publication of this review article.

Figures

Figure 1.
Figure 1.. Schematic formation of Candida albicans biofilm. (A) Attachment to an abiotic or a biotic surface. (B) Proliferation and transition to hyphae. (C) Production of extracellular matrix and maturation of biofilm. (D) Detachment of yeast cells and dispersion.

Similar articles

Cited by

References

    1. Cavalheiro M, Teixeira MC. Candida biofilms: Threats, challenges, and promising strategies. Front Med. 2018;5:28. doi: 10.3389/fmed.2018.00028. - DOI - PMC - PubMed
    1. Pereira R, dos Santos Fontenelle RO, de Brito EHS, et al. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol. 2021;131:11–22. doi: 10.1111/jam.14949. - DOI - PubMed
    1. Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, et al. Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis. PLoS One. 2022;17:e0263522. doi: 10.1371/journal.pone.0263522. - DOI - PMC - PubMed
    1. Pokhrel S, Boonmee N, Tulyaprawat O, et al. Assessment of biofilm formation by Candida albicans strains isolated from hemocultures and their role in pathogenesis in the zebrafish model. J Fungi. 2022;8:1014. doi: 10.3390/jof8101014. - DOI - PMC - PubMed
    1. Chen YN, Hsu JF, Chu SM, et al. Clinical and microbiological characteristics of neonates with candidemia and impacts of therapeutic strategies on the outcomes. J Fungi (Basel, Switzerland) 2022;8:465. doi: 10.3390/jof8050465. - DOI - PMC - PubMed

LinkOut - more resources